Anti-HBV and cytotoxic activities of pyranocoumarin derivatives

被引:96
|
作者
Su, Chung-Ren [1 ]
Yeh, Sheau Farn [2 ]
Liu, Chih Miem [2 ]
Damu, Amooru G. [1 ]
Kuo, Tsung-Hsiao [1 ]
Chiang, Po-Cheng [3 ]
Bastow, Kenneth F. [4 ]
Lee, Kuo-Hsiung [3 ]
Wu, Tian-Shung [1 ]
机构
[1] Natl Cheng Kung Univ, Dept Chem, Tainan 701, Taiwan
[2] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan
[3] Univ N Carolina, UNC Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, UNC Eshelman Sch Pharm, Div Med Chem & Nat Prod, Chapel Hill, NC 27599 USA
关键词
Pyranocoumarin derivatives; Anti-HBV; Cytotoxic; CHRONIC HEPATITIS-B; VIRUS; COUMARINS; THERAPY; ROOT;
D O I
10.1016/j.bmc.2008.12.007
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four natural pyranocoumarins clausenidin (1), nordentatin (2), clausarin (3), and xanthoxyletin (4) were isolated from the medicinal plant Clausena excavata. Recently, we found that 1 and 2 suppressed hepatitis B virus surface antigen in HepA2 cells, and in addition, 1-3 showed cytotoxic activity against four human cancer cell lines (A549, MCF7, KB, and KB-VIN). To explore the SAR of 1-4, 17 pyranocoumarin analogues (5-21) were designed and synthesized. Among these analogues, 5 and 10 were the most potent against hepatitis B virus with EC50 values of 1.14 and 1.34 mu M, respectively. The most interesting result in the cytotoxicity assay was the significant activity of 1, 5, and 6 against the multi-drug resistant cell line, KB-VIN, without activity against the KB cell line. These data suggest that these three compounds could be useful hits for developing MDR-inverse drugs. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6137 / 6143
页数:7
相关论文
共 50 条
  • [41] Anti-HBV Activities of Polysaccharides from Thais clavigera (Kuster) by In Vitro and In Vivo Study
    Tang, Fei
    Huang, Guanghua
    Lin, Liping
    Yin, Hong
    Shao, Lili
    Xu, Ruian
    Cui, Xiuling
    MARINE DRUGS, 2021, 19 (04)
  • [42] Synthesis and Anti-HBV Activity Evaluation of the Galactopyranosyl Derivatives of MTS Based on Click Reaction
    Yuan Jie
    Liu Qingchuan
    Xu Guangcan
    Liang Guangyi
    Xu Bixue
    CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE, 2016, 37 (07): : 1307 - 1319
  • [43] Development of anti-HBV agents targeting HBV capsid proteins
    Kobayakawa, Takuya
    Amano, Masayuki
    Nakayama, Miyuki
    Tsuji, Kohei
    Ishii, Takahiro
    Miura, Yutaro
    Shinohara, Kouki
    Yamamoto, Kenichi
    Matsuoka, Masao
    Tamamura, Hirokazu
    RSC MEDICINAL CHEMISTRY, 2023, 14 (10): : 1973 - 1980
  • [44] Anti-HBV effect of TAT- HBV targeted ribonuclease
    Ding, J
    Liu, J
    Xue, CF
    Gong, WD
    Li, YH
    Zhao, Y
    WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (07) : 1525 - 1528
  • [45] In vitro and in vivo anti-HBV activities of the new cyclophilin inhibitor STG-175
    Gallay, Philippe
    HEPATOLOGY, 2016, 64 : 936A - 936A
  • [46] Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents
    Qiu, Jingying
    Xu, Bixue
    Huang, Zhengming
    Pan, Weidong
    Cao, Peixue
    Liu, Changxiao
    Hao, Xiaojiang
    Song, Baoan
    Liang, Guangyi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (18) : 5352 - 5360
  • [47] Design and synthesis of pyridine-pyrazole-sulfonate derivatives as potential anti-HBV agents
    Chuang, Hong
    Huang, Lin-Chiang Sherlock
    Kapoor, Mohit
    Liao, Yi-Jen
    Yang, Cheng-Lin
    Chang, Chia-Ching
    Wu, Chun-Yi
    Hwu, Jih Ru
    Huang, Tsurng-Juhn
    Hsu, Ming-Hua
    MEDCHEMCOMM, 2016, 7 (05) : 832 - 836
  • [48] Entecavir - BMS-200475 - Anti-HBV
    不详
    DRUGS OF THE FUTURE, 2001, 26 (11) : 1107 - 1107
  • [49] IMPACT OF HBV VARIANT FITNESS ON THEIR SELECTION DURING ANTI-HBV THERAPY
    Villet, Stephanie
    Billioud, Gaetan
    Pichoud, Christian
    Lucifora, Julie
    Hantz, Olivier
    Sureau, Camille C.
    Deny, Paul
    Zoulim, Fabien
    HEPATOLOGY, 2008, 48 (04) : 677A - 677A
  • [50] Discovery and Development of Anti-HBV Agents and Their Resistance
    Kim, Kyun-Hwan
    Kim, Nam Doo
    Seong, Baik-Lin
    MOLECULES, 2010, 15 (09): : 5878 - 5908